Author/Authors :
Sotirova, Tatjana Ss Cyril and Methodius University - University Clinic of Hematology, Macedonia , Stojanovic, Aleksandar Ss Cyril and Methodius University - University Clinic of Hematology, Macedonia , Genadieva-Stavric, Sonja Ss Cyril and Methodius University - University Clinic of Hematology, Macedonia , Krstevska, Svetlana Ss Cyril and Methodius University - University Clinic of Hematology, Macedonia , Spasovski, Dejan Ss Cyril and Methodius University - University Clinic for Rheumatology, Macedonia , Balkanov, Trajan Ss Cyril and Methodius University - Institute for Pharmacology, Macedonia
Abstract :
Background: Accurate prediction of a patient’s prognosis is useful to define the risk posed by the disease. Age, gender, peripheral blood cytopenia, proportion of bone marrow (BM) blasts, performance status, comorbidities, transfusion dependence, specific karyotype abnormalities and molecular biomarkers can refine the prediction of prognosis in MDS. Aim: to assess the influence of the some prognostic factors like age, gender, cytopenia, BM blast percentage, transfusion dependence, ferritin, hemoglobin (Hb), lactate dehydrogenase (LDH), albumin and specifickaryotype abnormalities in myelodysplastic syndromes on overall survival (OS). Patients and methods: we retrospectively analyzed the cohort of 108 patients diagnosed between 1.1.2011 and 31.12.2013 at the University Clinic of Hematology, Ss Cyril and Methodius University, Skopje, Macedonia. They were evaluated for clinical and hematologic features at diagnosis and at leukemic transformation. Results: in the study group 62 were man and 46 women. Male to female ratio was 1.35 to 1. The differences in OS between men and women were significant (p = .03015).The mean age at diagnosis was 66,6 years. According to the age OS was 16,4 months. FAB subtypes influenced OS significantly (p = .03015). OS inversely correlated with BM blast percentage (p= .02327). Cytopenia had no impact on OS (p=.33755). Hb as a whole and groups with differentlevels of Hb had no influence on OS (p = .12142) and (p= .07535), respectively. The group with ferritin 500 μg/L had better OS (p=.04720). Transfusion dependence, LDH and albumin had no impact on OS. Leukemic transformation was noticed in 10 (9,3%) patients. Mortality was 36,1%. Conclusion: gender, FAB subtypes, BM blast percentage and the serum levels of ferritin had an influence on OS, while age, hemoglobin level, transfusion dependence, LDH and albumin had no impact on OS.
